October 24, 2023
The Cincinnati region is seeing an uptick in reports of fentanyl tainted with the horse tranquilizer xylazine. Cincinnati.com interviewed several local experts on the topic, including Richard Ryan, MD, of the Department of Emergency Medicine at the UC College of Medicine.
October 6, 2021
UC medical student Rohan Rao received unprecedented grant funding for summer brain tumor research in the lab of Soma Sengupta and Daniel Pomeranz Krummel and participates in a number of other College of Medicine activities in preparation for his goal to work as a clinician scientist.
May 26, 2023
University of Cincinnati Cancer Center researchers will present abstracts at the American Society of Clinical Oncology (ASCO) annual meeting 2023, held in Chicago June 2-6.
April 28, 2023
The University of Cincinnati's Christopher T. Richards, MD, was a recent guest on the Know Stroke Podcast to discuss mobile stroke units and where research is headed to improve care.
December 22, 2022
The University of Cincinnati's Christopher Richards, MD, co-authored an accompanying editorial to new research that showed high variability in the way EMS agencies document stroke cases, which was recently featured by MedPage Today.
May 5, 2023
The University of Cincinnati's Soma Sengupta was a co-first author on research published in Cell Reports Medicine New that found that a cancer stem cell test can accurately decide more effective treatments and lead to increased survival for patients with glioblastoma, a deadly brain tumor.
October 16, 2023
A collaborative team led by University of Cincinnati, University of North Carolina and Duke University researchers is studying how specific cancers and treatments affect patients' risk of stroke.
January 9, 2024
A new trial at the University of Cincinnati Gardner Neuroscience Institute, funded by a $660,000 National Institutes of Health (NIH) grant, will test an at-home tongue endurance exercise to improve patients’ swallowing function after a stroke.
February 6, 2024
A new University of Cincinnati trial, in partnership with Spark Biomedical, will test a wearable neurostimulation device to help patients with opioid use disorder and post-traumatic stress disorder stick with medication treatment while finding the right dose.
March 26, 2024
A multidisciplinary team of University of Cincinnati Cancer Center researchers have opened a Phase 2 clinical trial to test a new combination treatment for glioblastomas, the most deadly form of brain tumors.